Skip to content

Effectiveness of home visits and telemedicine for attention deficit hyperactivity disorder (ADHD) children patients in the community who loss to follow-up to return to continuity of treatment: Pilot randomized controlled trial

Effectiveness of home visits and telemedicine for attention deficit hyperactivity disorder (ADHD) children patients in the community who loss to follow-up to return to continuity of treatment: Pilot randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260608004
Enrollment
38
Registered
2026-06-08
Start date
2025-02-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder Loss to follow-up Continuity of care Attention Deficit Disorder with Hyperactivity ADHD Telemedicine Home Visits Continuity of Patient Care Patient Compliance Treatment Adherence and Compliance Follow-Up Studies Community Health Services Pediatric Mental Health

Interventions

Participants receive one home visit conducted by a multidisciplinary healthcare team, including a psychologist and public health personnel, combined with one telemedicine consultation with the treatin
Experimental Behavioral,Active Comparator Behavioral
Home Visit Combined with Telemedicine Consultation,Routine Telephone Follow-up

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 6 to 18 years. 2. Diagnosed with attention-deficit/hyperactivity disorder (ADHD). 3. Lost to follow-up, defined as missing two consecutive appointments, or missing one appointment and not receiving medication for at least six months, or absent from care for at least six months. 4. Able to be contacted by telephone. 5. Parent or legal guardian provides written informed consent.

Exclusion criteria

Exclusion criteria: 1. Parent or legal guardian refuses participation or declines informed consent. 2. Unable to be contacted after repeated telephone attempts. 3. Refuses home visit or telemedicine consultation. 4. Requires urgent psychiatric or medical treatment that prevents participation in the study.

Design outcomes

Primary

MeasureTime frame
Return to Continuous Treatment 3 months after intervention Attendance at scheduled follow-up visits for at least three consecutive months after intervention

Secondary

MeasureTime frame
SNAP-IV Score Baseline and 3 months after intervention SNAP-IV score

Countries

Thailand

Contacts

Public ContactPrawate Preedachaiyakul

Vachiraphuket hospital

Prawatepreeda@gmail.com0856640090

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026